Clement, M. S., Gammelgaard, K. R., Nielsen, A. L., & Sorensen, B. S. (2020). Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells. Transl Lung Cancer Res.
Chicago Style CitationClement, Michelle Simone, Kristine Raaby Gammelgaard, Anders Lade Nielsen, i Boe Sandahl Sorensen. "Epithelial-to-mesenchymal Transition Is a Resistance Mechanism to Sequential MET-TKI Treatment of MET-amplified EGFR-TKI Resistant Non-small Cell Lung Cancer Cells." Transl Lung Cancer Res 2020.
Cita MLAClement, Michelle Simone, Kristine Raaby Gammelgaard, Anders Lade Nielsen, i Boe Sandahl Sorensen. "Epithelial-to-mesenchymal Transition Is a Resistance Mechanism to Sequential MET-TKI Treatment of MET-amplified EGFR-TKI Resistant Non-small Cell Lung Cancer Cells." Transl Lung Cancer Res 2020.